Publication:
Triazolyl tryptoline derivatives as β-secretase inhibitors

dc.contributor.authorJutamas Jiaranaikulwanitchen_US
dc.contributor.authorChantana Boonyaraten_US
dc.contributor.authorValery V. Fokinen_US
dc.contributor.authorOpa Vajraguptaen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKhon Kaen Universityen_US
dc.contributor.otherScripps Research Instituteen_US
dc.date.accessioned2018-09-24T08:41:29Z
dc.date.available2018-09-24T08:41:29Z
dc.date.issued2010-11-15en_US
dc.description.abstractTryptoline, a core structure of ochrolifuanine E, which is a hit compound from virtual screening of the Thai herbal database against BACE1 was used as a scaffold for the design of BACE1 inhibitors. The tryptoline was linked with different side chains by 1,2,3-triazole ring readily synthesized by catalytic azide-alkyne cycloaddition reactions. Twenty two triazolyl tryptoline derivatives were synthesized and screened for the inhibitory action against BACE1. JJCA-140 was the most potent inhibitor (IC50= 1.49 μM) and was 100 times more selective for BACE1 than for Cat-D. © 2010 Elsevier Ltd. All rights reserved.en_US
dc.identifier.citationBioorganic and Medicinal Chemistry Letters. Vol.20, No.22 (2010), 6572-6576en_US
dc.identifier.doi10.1016/j.bmcl.2010.09.043en_US
dc.identifier.issn0960894Xen_US
dc.identifier.other2-s2.0-77958063689en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/28597
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77958063689&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTriazolyl tryptoline derivatives as β-secretase inhibitorsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77958063689&origin=inwarden_US

Files

Collections